Raymond James Financial
CTSO icon

Raymond James Financial’s Cytosorbents Corp CTSO Stock Holding History

Raymond James Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-5,381
Closed -$40.2K – 5506
2026
Q2 		$40.2K Sell
5,381
-7
-0.1% -$74 ﹤0.01% 5281
2026
Q1 		$61K Sell
5,388
-47
-0.9% -$642 ﹤0.01% 5098
2025
Q4 		$69.5K Sell
5,435
-1
-0% -$15 ﹤0.01% 4976
2025
Q3 		$102K Buy
5,436
+7
+0.1% +$138 ﹤0.01% 4748
2025
Q2 		$139K Sell
5,429
-88
-2% -$1.77K ﹤0.01% 4703
2025
Q1 		$110K Buy
5,517
+86
+2% +$1.81K ﹤0.01% 4534
2024
Q4 		$98.8K Buy
+5,431
New +$107K ﹤0.01% 4530

Other funds holding CTSO

Avenir Corporation
Avenir Corporation Alexandria, Virginia $812M AUM 0.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $36.2B AUM 20.53% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $867M AUM 20.76% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Raymond James Financial's CTSO Position: Q3 2026 in Review

Raymond James Financial sold out of Cytosorbents Corp (CTSO) in Q3 2026, closing a stake of 5,381 shares — an estimated $40.2K sold.

Raymond James Financial first reported a position in CTSO in Q4 2024 and held it in 7 quarters. The position peaked at $139K in Q2 2025. 25 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.

  • Raymond James Financial reported no remaining Cytosorbents Corp position as of Q3 2026 after selling out during the quarter.
  • Raymond James Financial sold 5,381 Cytosorbents Corp shares in Q3 2026, an estimated $40.2K.
  • Raymond James Financial first reported a position in Cytosorbents Corp in Q4 2024 and held it in 7 quarters.
  • Raymond James Financial's Cytosorbents Corp position peaked at $139K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.